Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Capital Expenditures: 2013-2022

Historic Capital Expenditures for vTv Therapeutics (VTVT) over the last 8 years, with Dec 2022 value amounting to $21,000.

  • vTv Therapeutics' Capital Expenditures was N/A to $18,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $128,000, marking a year-over-year change of. This contributed to the annual value of $21,000 for FY2022, which is N/A change from last year.
  • vTv Therapeutics' Capital Expenditures amounted to $21,000 in FY2022, which was down 70.00% from $70,000 recorded in FY2019.
  • vTv Therapeutics' 5-year Capital Expenditures high stood at $70,000 for FY2019, and its period low was $5,000 during FY2018.
  • Over the past 1 years, vTv Therapeutics' median Capital Expenditures value was $21,000 (recorded in 2022), while the average stood at $21,000.
  • Per our database at Business Quant, vTv Therapeutics' Capital Expenditures plummeted by 91.23% in 2018 and then surged by 1,300.00% in 2019.
  • Yearly analysis of 3 years shows vTv Therapeutics' Capital Expenditures stood at $5,000 in 2018, then surged by 1,300.00% to $70,000 in 2019, then reached $21,000 in 2022.